Gomisin N Alleviates Ethanol-Induced Liver Injury through Ameliorating Lipid Metabolism and Oxidative Stress
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES19(9) · 2018
- 피인용
- Web of Science 50Scopus 52
- FWCI (Scopus)
- 1.51
- JCR IF
- JCR 2017 3.687
- ISSN
- 1661-6596
저자
- 아룰쿠마 나가판제1저자Healthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- 정대영Healthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- 김지현Healthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, South Korea
- Lee, HoyoungKM Fundamental Research Division, Korea Institute of Oriental Medicine, Daejeon, South Korea
- 정명호교신저자Healthy Aging Korean Medical Research Center, School of Korean Medicine, Pusan National University, Yangsan, South Korea
초록
Gomisin N (GN), a lignan derived from Schisandra chinensis, has been shown to possess antioxidant, anti-inflammatory, and anticancer properties. In the present study, we investigated the protective effect of GN against ethanol-induced liver injury using in vivo and in vitro experiments. Histopathological examination revealed that GN administration to chronic-binge ethanol exposure mice significantly reduced ethanol-induced hepatic steatosis through reducing lipogenesis gene expression and increasing fatty acid oxidation gene expression, and prevented liver injury by lowering the serum levels of aspartate transaminase and alanine transaminase. Further, it significantly inhibited cytochrome P450 2E1 (CYP2E1) gene expression and enzyme activity, and enhanced antioxidant genes and glutathione level in hepatic tissues, which led to decreased hepatic malondialdehyde levels. It also lowered inflammation gene expression. Finally, GN administration promoted hepatic sirtuin1 (SIRT1)-AMP-activated protein kinase (AMPK) signaling in ethanol-fed mice. Consistent with in vivo data, treatment with GN decreased lipogenesis gene expression and increased fatty acid oxidation gene expression in ethanol-treated HepG2 cells, thereby preventing ethanol-induced triglyceride accumulation. Furthermore, it inhibited reactive oxygen species generation by downregulating CYP2E1 and upregulating antioxidant gene expression, and suppressed inflammatory gene expression. Moreover, GN prevented ethanol-mediated reduction in SIRT1 and phosphorylated AMPK. These findings indicate that GN has therapeutic potential against alcoholic liver disease through inhibiting hepatic steatosis, oxidative stress and inflammation.
키워드
alcoholic liver diseaseAMP-activated protein kinasecytochrome P450 2E1gomisin Nhepatic steatosisoxidative stresssirtuin1ENDOPLASMIC-RETICULUM STRESSHEPATIC STEATOSISFATTY LIVERDISEASEAMPKACTIVATIONHOMEOSTASISALCOHOLCYP2E1SIRT1
식별자
- Scopus EID
- 2-s2.0-85052815743
- WoS UID
- 000449988100137



로그인
연구물 목록으로